Ketamine therapy has exploded, for treatment-resistant depression, chronic pain, and more, and with that growth comes a liability profile that many practices do not fully grasp. Ketamine is one of the fastest-growing and least-understood risks in wellness medicine today.
What sets ketamine apart is that it combines several high-risk elements at once. It is a controlled substance, which brings DEA and state controlled-substance rules into play, including the telemedicine-prescribing framework now approaching its December 31, 2026 deadline. It is a psychoactive treatment, which raises questions of patient screening, monitoring during administration, and managing dissociative effects. And it often serves psychologically vulnerable patients, which heightens the duty of care.
The liability exposures are correspondingly layered. Patient selection and screening: was the patient appropriately evaluated, including mental-health screening? Monitoring: was the patient observed and supported during and after administration? Setting and emergency readiness: could the practice handle an adverse psychological or physiological reaction? Controlled-substance compliance: is prescribing, storage, and recordkeeping fully compliant with DEA and state rules, including prescription-monitoring-program checks? Informed consent: were the risks, including dissociative effects and the off-label nature of many uses, honestly disclosed?
Telemedicine adds complexity. As a controlled substance, ketamine prescribing intersects directly with the evolving DEA telemedicine rules, and at-home ketamine models have drawn particular regulatory attention. A practice built on remote ketamine prescribing needs to watch this framework closely.
On coverage, ketamine sits at the intersection of aesthetics, mental health, and controlled substances, and many standard policies are not built for it. A practice offering ketamine needs professional liability coverage that specifically contemplates it, and should assume that a generic policy may not.
A defensible ketamine practice looks like this: rigorous patient screening including mental health, monitored administration in an appropriate setting, airtight controlled-substance compliance, honest and thorough informed consent, careful attention to the telemedicine rules, and coverage explicitly built for ketamine services.
In over 25 years in this industry, ketamine is one of the clearest examples of a service growing faster than most practices' understanding of its risk, and faster than the coverage many of them carry.
Ketamine therapy is doing real good for real patients. But it demands a level of clinical rigor, compliance, and coverage that matches its complexity, not the casual approach its popularity sometimes invites.
Ketamine sits where controlled substances, mental health, and telemedicine intersect, and most standard policies were not built for it. We specialize in coverage for complex wellness services and bring over 25 years of experience. Check your eligibility and make sure your ketamine practice is truly protected.
Check Your EligibilityWhy is ketamine therapy considered high-liability?
It combines several high-risk elements: it is a controlled substance with DEA and state rules, a psychoactive treatment requiring screening and monitoring, and it often serves psychologically vulnerable patients. Each adds a layer of exposure.
Does the DEA telemedicine deadline affect ketamine clinics?
Yes. Ketamine is a controlled substance, so its remote prescribing is governed by the DEA telemedicine flexibilities currently extended through December 31, 2026. At-home ketamine models have drawn particular regulatory attention.
What does a defensible ketamine practice require?
Rigorous patient screening including mental health, monitored administration in an appropriate setting, full controlled-substance compliance, honest informed consent, careful attention to telemedicine rules, and coverage built specifically for ketamine.
Will a standard policy cover ketamine services?
Often not adequately. Ketamine sits at the intersection of aesthetics, mental health, and controlled substances, which many standard policies are not designed for. Specialized coverage that specifically contemplates ketamine is needed.
[[YULIA_DISCLAIMER]]
Running or launching a ketamine service? Schedule a free consultation. We will make sure your coverage is built for its unique risks, not a generic policy that leaves gaps.
Schedule a Free Consultation